Fed. Circ. To Weigh In On Written Description Rule
In a case that could make patents easier to prosecute and tougher to invalidate, a federal appeals court is gearing up for an en banc rehearing of Ariad Pharmaceuticals Inc.'s patent...To view the full article, register now.
Already a subscriber? Click here to view full article